Skip to main content

Table 1 Summary of patient data

From: Safety of MR-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas

Patient number

Age (years)

Treated pedunculated leiomyoma

Stalk

Number of leiomyomas treated

Complications

Alternative treatment

Follow-up (months)

  

Largest diameter (cm)

Volume (cm3)

NPV (cm3)

NPV/LV

Diameter (cm)

SD/LD

Total

Pedunculated

   

1

47

10.6

477

122

0.26

5.1

0.48

4

1

No

No

36

2

39

8

170

73

0.43

3.7

0.46

4

3

No

Yes

3

3

37

13

351

60

0.17

3.5

0.27

8

1

No

Yes

45

4

46

10.4

370

102

0.28

2.7

0.26

3

1

No

Yes

46

5

40

5.9

83

15

0.19

1.8

0.31

1

1

No

No

26

6

33

11

478

196

0.41

4.8

0.44

2

1

No

Yes

16

7

52

11.5

522

218

0.42

3.9

0.34

1

1

No

No

36

8

41

6.9

105

16

0.16

3.3

0.48

3

1

Yes

No

14

9

51

11.7

645

523

0.81

3.6

0.31

1

1

Yes

No

15

10

35

11

482

215

0.45

3.9

0.35

1

1

No

No

14

11

47

9.9

376

23

0.06

1.6

0.16

2

1

No

No

4

Average

42.5

10

369

142

0.33

3.4

0.36

2.7

1.2

-

-

23.2

Minimum

33

5.9

83

15

0.06

1.6

0.16

1

1

-

-

3

Maximum

52

13

645

523

0.81

5.1

0.48

8

3

-

-

46

  1. Abbreviations: cm, centimeters; cm3, cubic centimeters; NPV, non-perfused volume; LV, leiomyoma volume; SD, stalk diameter; LD, leiomyoma diameter. Age is at the time of FUS treatment. Follow-up is the duration of clinical follow-up that was available.